Global Axial Spondyloarthritis Market To Reach USD 8 79 Billion By 2030 Amid Advancements In Treatment Modalities And Drug Classes menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Israel’s Teva Pharmaceuticals received approval from the Food and Drug Administration for the SIMLANDI (adalimumab-ryvk) injection, for the treatment of a number of different forms of arthritis, colitis and Chron’s Disease, among others. The drug is developed together with Iceland’s Alvotech and its marketing could lead to billions in sales. SIMLANDI is the first high-concentration, […]